Proequities, Inc.

SEC CIK: 0000752798
Latest filing: Aug 12, 2025

SEC filings (opens in a new tab)

RETA holding history

Reata Pharmaceuticals Inc in every 13F filed by Proequities, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RETA overview All 13F holders of RETA Full Q2 2025 holdings

Shares (Q3 2021): 0; Sold out in Q3 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of RETA by Proequities, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2021	0	$0	0.0%	−165−100.0%	Sold out	Holders
Q2 2021	165	$23.0K	<0.1%	00.0%	Unchanged	Holders
Q1 2021	165	$16.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.